Thomas Makatsoris

2.2k total citations
85 papers, 1.5k citations indexed

About

Thomas Makatsoris is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Thomas Makatsoris has authored 85 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 18 papers in Molecular Biology. Recurrent topics in Thomas Makatsoris's work include Colorectal Cancer Treatments and Studies (25 papers), Cancer Treatment and Pharmacology (21 papers) and Lung Cancer Treatments and Mutations (12 papers). Thomas Makatsoris is often cited by papers focused on Colorectal Cancer Treatments and Studies (25 papers), Cancer Treatment and Pharmacology (21 papers) and Lung Cancer Treatments and Mutations (12 papers). Thomas Makatsoris collaborates with scholars based in Greece, United Kingdom and United States. Thomas Makatsoris's co-authors include Haralabos P. Kalofonos, Andreas A. Argyriou, Athanasios P. Kyritsis, Αngelos Koutras, George Fountzilas, Gerasimos Aravantinos, Dimitrios Pectasides, Gregoris Iconomou, Dimitrios Bafaloukos and Konstantinos Assimakopoulos and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Thomas Makatsoris

82 papers receiving 1.5k citations

Peers

Countries citing papers authored by Thomas Makatsoris

Since Specialization

Citations

This map shows the geographic impact of Thomas Makatsoris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Makatsoris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Makatsoris more than expected).

Fields of papers citing papers by Thomas Makatsoris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Makatsoris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Makatsoris. The network helps show where Thomas Makatsoris may publish in the future.

Co-authorship network of co-authors of Thomas Makatsoris

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Makatsoris. A scholar is included among the top collaborators of Thomas Makatsoris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Makatsoris. Thomas Makatsoris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer (A-REPEAT study): efficacy and correlations with tissue and plasma genotyping 2025 ·PubMed ·Joseph Sgouros, Alexia Eliades, Kyriaki Papadopoulou, Nikolaos Korfiatis, Demetris Papamichael, Elena Fountzilas, Eleftheria Tsolaki, Achilleas Achilleos, Kyriakos Tsangaras, (unknown), (unknown), Thomas Makatsoris, (unknown), Maria G. Ioannides, George Koumbaris, (unknown), Philippos C. Patsalis, George Pentheroudakis	0
2	Exploring Bevacizumab's Role in Gynecological Cancers: An Up-to-Date Narrative Review Focusing on Ovarian Cancer 2024 ·Materia Socio Medica ·Elias Liolis, Francesk Mulita, Αngelos Koutras, Thomas Makatsoris, Gregory Sivolapenko	2
3	Association of overexpression of TNF receptor superfamily members (CD40, BAFFR, LTβR and RANK) with favorable prognosis in patients with colorectal adenocarcinoma. 2024 ·Journal of Clinical Oncology ·Αναστασία Κοττόρου, Foteinos‐Ioannis Dimitrakopoulos, Anna G. Antonacopoulou, Thomas Makatsoris, Vassiliki Tzelepi, Haralabos P. Kalofonos, Αngelos Koutras	2
4	Small Extracellular Vesicles (sEVs) Biogenesis Molecular Players Are Associated with Clinical Outcome of Colorectal Cancer Patients 2023 ·Cancers ·Αναστασία Κοττόρου, Foteinos‐Ioannis Dimitrakopoulos, (unknown), Foteini Kalofonou, (unknown), (unknown), Thomas Makatsoris, Αngelos Koutras, Haralabos P. Kalofonos	5
5	Health-related quality of life in patients with solid tumors receiving implantable venous access ports for chemotherapy: A prospective randomized controlled trial 2023 ·European Journal of Oncology Nursing ·(unknown), Gregoris Iconomou, Konstantinos Assimakopoulos, (unknown), Thomas Makatsoris, Αngelos Koutras, Dimitrios Karnabatidis, Konstantinos Katsanos	2
6	Analysis of RANK-c interaction partners identifies TRAF3 as a critical regulator of breast cancer aggressiveness 2022 ·Neoplasia ·Chaido Sirinian, (unknown), Özge Karayel, Søren E. Degn, (unknown), Dimitrios Chaniotis, (unknown), Maria Repanti, Mark Kriegsmann, Thomas Makatsoris, Αngelos Koutras, Matthias Mann, Haralabos P. Kalofonos	1
7	Diagnostic value of methylation status of T-UCRs for colorectal cancer 2016 ·Annals of Oncology ·Αναστασία Κοττόρου, Anna G. Antonacopoulou, Foteinos‐Ioannis Dimitrakopoulos, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Evangelos Katsakoulis, A. Koutras, Thomas Makatsoris, (unknown), K. Thomopoulos, Haralabos P. Kalofonos	1
8	Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG) 2015 ·World Journal of Urology ·Konstantinos Koutsoukos, Kimon Tzannis, Christos Christodoulou, Vasilios Karavasilis, (unknown), Thomas Makatsoris, Christos N. Papandreou, Dimitrios Pectasides, Meletios Α. Dimopoulos, Aristotelis Bamias	3
9	Immune Response Gene Expression in Colorectal Cancer Carries Distinct Prognostic Implications According to Tissue, Stage and Site: A Prospective Retrospective Translational Study in the Context of a Hellenic Cooperative Oncology Group Randomised Trial 2015 ·PLoS ONE ·George Pentheroudakis, (unknown), Vassiliki Kotoula, Ralph M. Wirtz, Eleni Vrettou, Vasilios Karavasilis, (unknown), (unknown), Konstantinos N. Syrigos, Evangelos Bournakis, (unknown), Ioannis Varthalitis, Eleni Galani, Georgios Lazaridis, George Papaxoinis, Dimitrios Pectasides, Gerasimos Aravantinos, Thomas Makatsoris, Konstantine T. Kalogeras, George Fountzilas	18
10	The first case of Staphylococcus aureus ST398 causing bacteremia in an immunocompromised patient in Greece 2012 ·Indian Journal of Medical Microbiology ·Ελεάννα Δρούγκα, Antigoni Foka, (unknown), Apostolos Liakopoulos, Thomas Makatsoris, E. D. Anastassiou, Efthimia Petinaki, Iris Spiliopoulou	8
11	Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial 2012 ·Cancer Chemotherapy and Pharmacology ·Kyriaki Pliarchopoulou, Konstantine T. Kalogeras, Ralf Kronenwett, Ralph M. Wirtz, Anastasia G Eleftheraki, Anna Batistatou, Mattheos Bobos, (unknown), Genovefa Polychronidou, Helen Gogas, E. Samantas, Christos Christodoulou, Thomas Makatsoris, Nicholas Pavlidis, Dimitrios Pectasides, George Fountzilas	47
12	Improved Outcome of High-Risk Early HER2 Positive Breast Cancer With High CXCL13-CXCR5 Messenger RNA Expression 2012 ·Clinical Breast Cancer ·Evangelia Razis, Konstantine T. Kalogeras, Vassiliki Kotoula, Anastasia G Eleftheraki, Nikitas Nikitas, Ralf Kronenwett, Eleni Timotheadou, Christos Christodoulou, Dimitrios Pectasides, Helen Gogas, Ralph M. Wirtz, Thomas Makatsoris, Dimitrios Bafaloukos, Gerasimos Aravantinos, Despina Televantou, Nicholas Pavlidis, George Fountzilas	46
13	Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study 2011 ·Annals of Oncology ·Amanda Psyrri, Konstantine T. Kalogeras, Ralf Kronenwett, Ralph M. Wirtz, Anna Batistatou, Evangelos Bournakis, Eleni Timotheadou, Helen Gogas, Gerasimos Aravantinos, Christos Christodoulou, Thomas Makatsoris, Helena Linardou, Dimitrios Pectasides, Nicholas Pavlidis, Theofanis Economopoulos, George Fountzilas	61
14	Prolonged survival of neoplastic meningitis from breast cancer with letrozole and intrathecal methotrexate: a case report 2010 ·Journal of Neuro-Oncology ·(unknown), (unknown), Ioannis Starakis, Αngelos Koutras, Thomas Makatsoris, (unknown), Haralabos P. Kalofonos	9
15	Phase II Study of Irinotecan plus Leucovorin and Bolus 5-Fluorouracil as First- or Second-Line Chemotherapy in Patients with Advanced Gastric or Esophageal-Gastric Junction Adenocarcinoma 2007 ·Journal of Chemotherapy ·A. Koutras, Miltiadis Gerolymos, (unknown), Gregoris Iconomou, Georgia Vourli, (unknown), Thomas Makatsoris, (unknown), Haralabos P. Kalofonos	2
16	Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer 2007 ·Medical Oncology ·Thomas Makatsoris, Pavlos Papakostas, Haralabos P. Kalofonos, Ioannis Xanthakis, D. Tsavdaridis, Gerasimos Aravantinos, Helen Gogas, G. Klouvas, P. Kosmidis, Dimitrios Pectasides, George Fountzilas	4
17	Mitoxantrone Plus Vinorelbine in Pretreated Patients with Metastatic Breast Cancer 2007 ·Journal of Chemotherapy ·(unknown), Helen Gogas, Christos Markopoulos, Dimitrios Bafaloukos, Gerasimos Aravantinos, Marina Mantzourani, A. Koutras, (unknown), Nikolaos I. Xiros, Thomas Makatsoris, George Fountzilas, Haralabos P. Kalofonos	13
18	Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non–nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group 2006 ·Annals of Oncology ·George Fountzilas, Pavlos Papakostas, Urania Dafni, Thomas Makatsoris, M. Karina, Anna Kalogera‐Fountzila, N Maniadakis, Gerasimos Aravantinos, (unknown), Aristotelis Bamias, Christos Christodoulou, Theofanis Economopoulos, Haralabos P. Kalofonos, Angelos Nikolaou, Nikolaos Angouridakis, George P. Stathopoulos, Dimitrios Bafaloukos, Nicholas Pavlidis, J. Daniilidis	22
19	A Phase II Study of Capecitabine Plus Oxaliplatin (XELOX): A New First-Line Option in Metastatic Colorectal Cancer 2005 ·International Journal of Gastrointestinal Cancer ·Thomas Makatsoris, Haralabos P. Kalofonos, Gerasimos Aravantinos, Christos Papadimitriou, Efstathios Kastritis, (unknown), Nikolaos I. Xiros, Theodore Petsas, Theofanis Economopoulos, (unknown), George Fountzilas	27
20	Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) 2004 ·Anti-Cancer Drugs ·Jim Janinis, George P. Stathopoulos, Paul Nikolaidis, Haralabos P. Kalofonos, Anna Kalogera‐Fountzila, E. Samantas, Gerasimos Aravantinos, (unknown), (unknown), Thomas Makatsoris, S. Rigatos, Dimitrios Bafaloukos, Meletios Α. Dimopoulos, (unknown), George Fountzilas	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact